S&P 500 Futures
(0.15%) 5 335.00 points

Dow Jones Futures
(0.08%) 40 169 points

Nasdaq Futures
(0.21%) 18 675 points

Oil
(-0.01%) $80.05

Gas
(1.75%) $2.67

Gold
(1.03%) $2 442.20

Silver
(4.08%) $32.54

Platinum
(0.96%) $1 100.50

USD/EUR
(-0.09%) $0.919

USD/NOK
(-0.16%) $10.66

USD/GBP
(0.01%) $0.787

USD/RUB
(0.12%) $91.08

Realtime updates for Celon Pharma S.A. [CLN.WA]

Exchange: WSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-21)

Expected move: +/- 0.00%

Last Updated17 May 2024 @ 11:00

25% discount on Stockinvest.us - Use code: Podcast

1.20% PLN 16.84

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:00):

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments...

Stats
Today's Volume	65 315.00
Average Volume	29 002.00
Market Cap	859.79M
EPS	PLN-0.130 ( 2023-11-22 )
Next earnings date	( PLN0 ) 2024-05-21
Last Dividend	PLN0.0900 ( 2023-06-29 )
Next Dividend	PLN0 ( N/A )
P/E	-30.62
ATR14	PLN0.0170 (0.10%)

Volume Correlation

Long: 0.10 (neutral)

Short: -0.28 (neutral)

Signal:(46.981) Neutral

Celon Pharma S.A. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celon Pharma S.A. Correlation - Currency/Commodity

-0.66
( moderate negative )

-0.55
( weak negative )

0.00
( neutral )

-0.32
( neutral )

0.53
( weak )

0.56
( weak )

Celon Pharma S.A. Financials

Annual	2023
Revenue:	PLN164.39M
Gross Profit:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2023
Revenue:	PLN164.39M
Gross Profit:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2022
Revenue:	PLN161.92M
Gross Profit:	PLN95.45M (58.95 %)
EPS:	PLN-0.770

FY	2021
Revenue:	PLN169.56M
Gross Profit:	PLN107.84M (63.60 %)
EPS:	PLN-0.111

Financial Reports:

No articles found.

Celon Pharma S.A. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0.0900 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)

Celon Pharma S.A. Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.652 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	PLN0.170	2017-05-31
Last Dividend	PLN0.0900	2023-06-29
Next Dividend	PLN0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	PLN1.110	--
Avg. Dividend % Per Year	0.00%	--
Score	0.65	--
Div. Sustainability Score	1.652
Div.Growth Potential Score	0
Div. Directional Score	0.271	--

Next Divdend (Est)
(2025-04-08)

PLN0.0386 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

0.65

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for WSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ABS.WA	Ex Dividend Knight	2023-06-07	Annually	0	0.00%
KRU.WA	Ex Dividend Knight	2023-09-06	Annually	0	0.00%
GPP.WA	Ex Dividend Junior	2023-06-29	Annually	0	0.00%
WLT.WA	Ex Dividend Junior	2023-08-01	Annually	0	0.00%
CMR.WA	Ex Dividend Junior	2023-07-07	Sporadic	0	0.00%
RBW.WA	Ex Dividend Junior	2023-08-16	Sporadic	0	0.00%
BDX.WA	Ex Dividend Knight	2023-05-24	Annually	0	0.00%
OPL.WA	Ex Dividend Junior	2023-07-11	Sporadic	0	0.00%
APR.WA	Ex Dividend Junior	2023-05-31	Sporadic	0	0.00%
LVC.WA	Ex Dividend Knight	2023-08-24	Semi-Annually	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.135	1.500	-2.69	-4.04	[0 - 0.5]
returnOnAssetsTTM	-0.0388	1.200	-1.295	-1.554	[0 - 0.3]
returnOnEquityTTM	-0.0481	1.500	-1.645	-2.47	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.20	0.800	4.01	3.21	[1 - 3]
quickRatioTTM	1.893	0.800	3.57	2.86	[0.8 - 2.5]
cashRatioTTM	0.375	1.500	9.03	10.00	[0.2 - 2]
debtRatioTTM	0.0449	-1.500	9.25	-10.00	[0 - 0.6]
interestCoverageTTM	-8.21	1.000	-4.15	-4.15	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.801	2.00	-0.400	-0.801	[0 - 20]
debtEquityRatioTTM	0.0574	-1.500	9.77	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.606	1.000	3.24	3.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.131	1.000	-4.62	-4.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.325	1.000	-2.92	-2.92	[0.2 - 2]
assetTurnoverTTM	0.289	0.800	-1.408	-1.127	[0.5 - 2]
Total Score				1.652

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-39.11	1.000	-4.05	0	[1 - 100]
returnOnEquityTTM	-0.0481	2.50	-1.058	-2.47	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.801	2.00	-0.267	-0.801	[0 - 30]
dividendYielPercentageTTM	0.534	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.85	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0506	1.000	-3.76	0	[0.1 - 0.5]
Total Score				-1.110

Celon Pharma S.A. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Celon Pharma S.A.

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.